ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

JBDI vs TMO // GROSS PROFIT MARGIN

JBDI Holdings Limited (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: JBDI 0 — TMO 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JBDI VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC JBDI TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 49.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 9.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -2.01% 2.40% -4.41 TMO /fcf-yield <GO>
Operating Margin -2.00% 17.40% -19.40 TMO /operating-margins <GO>
Net Profit Margin 1.40% 15.10% -13.70 TMO /net-margins <GO>
Revenue Growth (YoY) 0.90% 3.90% -3.00 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.6 62.9 -3.27 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $22.9M $262.22B -$262.19B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR JBDI REV TMO REV JBDI GROSS % TMO GROSS % JBDI FCF TMO FCF
FY 2025 $8.5M $44.56B 49.9% — -$462.0K $6.29B
FY 2024 $8.4M $42.88B 39.7% — -$3.4M $7.27B
FY 2023 $9.4M $42.86B — — $1.0M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JBDI // BETA —
TMO // BETA 0.94